Dr. Sophia Ying Wang, MD

Dr. Wang practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Wang's NPI, 1255674461, was assigned on April 5, 2013. Dr. Wang graduated from University of California, San Francisco School of Medicine in 2013. Dr. Wang holds California license A147902.

Dr. Wang's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Wang's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Wang to 1 more hospital and 1 medical group, each named with a free account. Dr. Wang's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 2 sites in all. Vendor and product names are available with a free account.

Glaucoma specialist is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Dr. Wang is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Wang's licenses on file in 2 states: California and Michigan.

CMS data shows 454 Medicare services from Dr. Wang across 7 procedure codes in 2024, for 126 Medicare patients. Medicare paid $18,731 for them. Every service was in an office.

CMS counts 126 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 68, with 52% women.

In 2024, Dr. Wang wrote 272 Medicare Part D claims for 56 patients. 40% of them were for generic drugs. CMS names the drug for 225 of them, across 6 drugs with 11 or more claims each, at $16,259 in total drug cost. In 2023, CMS named 149 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of cataract surgery by Dr. Wang, more than 42% of the clinicians it reports for that procedure.

Dmand AI links 77 papers to Dr. Wang, published from 2012 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Glaucoma, Electronic Health Records and Intraocular Pressure. Dr. Wang has published most often in Ophthalmol Sci. Dr. Wang's most frequent co-authors are Kuldev Singh, MD, Shan C. Lin, MD and Robert T. Chang, MD.

CMS Open Payments shows 43 general payments to Dr. Wang from 10 drug and device companies from 2017 to 2025. Grants make up the largest share, 95% of the total. Alcon Research Ltd paid the most, $75,992.

Dr. Wang graduated from University of California, San Francisco School of Medicine in 2013.

Dr. Wang is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.